Bill

BILL • US HOUSE

HR 4055

Dialysis-Related Amyloidosis Treatment Act of 2025

119th Congress

Overview: HR 4055, the Dialysis-Related Amyloidosis Treatment Act of 2025, is a bill introduced in the House that aims to improve access to treatment for individuals with dialysis-

Introduced in House
0
0
Bill Summary • HR 4055

Overview: HR 4055, the Dialysis-Related Amyloidosis Treatment Act of 2025, is a bill introduced in the House that aims to improve access to treatment for individuals with dialysis-related amyloidosis.

Purpose and Intent: The bill recognizes the significant health challenges faced by patients with dialysis-related amyloidosis, a condition that can develop as a complication of long-term dialysis treatment. The legislation seeks to ensure that these patients have access to the necessary medical care and support.

Key Provisions:
- Requires Medicare and private insurance plans to cover the costs of treatment for dialysis-related amyloidosis
- Establishes a grant program to fund research and development of new therapies for the condition
- Directs the Department of Health and Human Services to develop educational resources for healthcare providers and patients

Affected Parties and Impacts: The bill would directly benefit individuals with dialysis-related amyloidosis by improving their access to treatment and reducing the financial burden. It would also support healthcare providers and researchers working to address this condition.

Procedural and Timeline Considerations: The bill has been introduced in the House and is currently under consideration. If passed, the provisions would take effect within a specified timeframe to ensure timely implementation.

Hi! I'm your AI assistant for HR 4055. I can help you understand its provisions, impacts, and answer any questions.

Key Provisions Impacts Timeline
Sign in to chat

Start the Conversation

Be the first to share your thoughts on this petition. Your voice matters!

Share your opinion above